Monte Rosa Therapeutics stock price
몬테 로사 테라퓨틱스NASDAQ:GLUE · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Monte Rosa Therapeutics last closed at $10.50 (-6.75%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -5.6×. Its overall grade ranks 556 of 739 stocks in Healthcare.
About this company
Monte Rosa Therapeutics last closed at $10.50 (-6.75%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 556/739
Valuation grade B-
Related stocks
- RocheCustomer
Monte Rosa의 분자글루 표적 단백질 분해(Molecular Glue Degrader) 플랫폼에 대한 전략적 파트너
- NovartisCustomer
Monte Rosa의 신약 후보 물질 공동개발·라이선스 파트너
- MerckCompetitor
항암·면역 질환 분야에서 신규 저분자/표적치료제 경쟁
About Monte Rosa Therapeutics
- What technical signals does Monte Rosa Therapeutics (GLUE) have?
- Monte Rosa Therapeutics current technical signals: no active technical signal.
- Is Monte Rosa Therapeutics a cup-and-handle pattern?
- No. Monte Rosa Therapeutics has no valid Cup signal right now.
- What published figures are available for Monte Rosa Therapeutics?
- Market cap: $683.74M. Trailing 12 months PER: -5.6×. Latest quarter PBR: 1.84×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Monte Rosa Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).